Can GSTP1 rs1695 AG reduce detoxification of reactive estrogen quinones?

During catechol-estrogen metabolism, estrogens are oxidized into highly reactive catechol estrogen quinones. In breast and other hormone-sensitive tissues, glutathione S-transferase P1 (GSTP1) serves as a critical enzymatic defense by conjugating these electrophiles with glutathione to neutralize their mutagenic potential.

Mechanistic pathways

• Enzymatic alteration: The GSTP1 rs1695 polymorphism causes an isoleucine-to-valine substitution at codon 105 (Ile105Val), structurally modifying the enzyme's substrate-binding pocket.
• Reduced detoxification capacity: The AG genotype (carrying the Val105 variant) exhibits altered catalytic efficiency, typically resulting in a reduced detoxification capacity for many electrophilic substrates.
• Genotoxic risk: When active GSTP1 is insufficient to clear reactive quinones (derived from 2- and 4-hydroxyestradiol), these electrophiles accumulate and react with DNA. This leads to the formation of depurinating estrogen-DNA adducts, which initiate mutagenic pathways.

Clinical implications and limitations

• Substrate dependency: Although the rs1695 variant clearly modulates general electrophilic clearance, direct variant-specific kinetic parameters (such as $K_m$ and $V_{max}$) specifically for estrogen quinone substrates are not yet fully established. Its role in reducing estrogen quinone detoxification is heavily supported but partly inferential.
• Hormonal tissue defense: Because GSTP1 is the predominant GST isoform in breast tissue, genetic variations that lower its activity are crucial factors in individual susceptibility to estrogen-induced oxidative stress, particularly during periods of hormonal transition.

Bottom line

• The GSTP1 rs1695 AG genotype alters the enzyme's binding pocket and reduces its capacity to detoxify various electrophilic compounds. This can compromise the neutralization of reactive estrogen quinones, potentially increasing the risk of depurinating estrogen-DNA adducts in hormone-sensitive tissues.